The pharmacology of dobutamine.
暂无分享,去创建一个
[1] C. Leier,et al. Drugs five years later. Dobutamine. , 1983, Annals of internal medicine.
[2] R. Ruffolo. The mechanism of action of dobutamine. , 1984, Annals of internal medicine.
[3] H. Loeb,et al. Superiority of Dobutamine over Dopamine for Augmentation of Cardiac Output in Patients with Chronic Low Output Cardiac Failure , 1977, Circulation.
[4] H. Schümann,et al. α-Adrenoceptors in the ventricular myocardium: clonidine, naphazoline and methoxamine as partial α-agonists exerting a competitive dualism in action to phenylephrine , 1976 .
[5] R. Ruffolo,et al. Alpha and beta adrenergic effects of the stereoisomers of dobutamine. , 1981, The Journal of pharmacology and experimental therapeutics.
[6] R. Ruffolo,et al. Inotropic selectivity of dobutamine enantiomers in the pithed rat. , 1985, The Journal of pharmacology and experimental therapeutics.
[7] R. Ruffolo,et al. Systemic hemodynamic effects of dopamine, (+/-)-dobutamine and the (+)-and (-)-enantiomers of dobutamine in anesthetized normotensive rats. , 1985, European journal of pharmacology.
[8] J. Cohn,et al. Treatment of refractory heart failure with infusion of nitroprusside. , 1974, The New England journal of medicine.
[9] L. Jarett,et al. Chemical Pathology , 1907, The Indian Medical Gazette.
[10] W. Parmley,et al. The role of vasodilator therapy in heart failure. , 1977, Progress in cardiovascular diseases.
[11] R. Tuttle,et al. Dobutamine: DEVELOPMENT OF A NEW CATECHOLAMINE TO SELECTIVELY INCREASE CARDIAC CONTRACTILITY , 1975, Circulation research.
[12] E. Sonnenblick,et al. Dobutamine: a new synthetic cardioactive sympathetic amine. , 1979, The New England journal of medicine.
[13] C. Bush,et al. The Cardiovascular Effects of the Continuous Infusion of Dobutamine in Patients with Severe Cardiac Failure , 1977, Circulation.
[14] D. Nutter,et al. In Vivo Analysis of Adrenergic Receptor Activity of Dobutamine , 1974, Circulation Research.
[15] C. Leier,et al. Comparative Systemic and Regional Hemodynamic Effects of Dopamine and Dobutamine in Patients with Cardiomyopathic Heart Failure , 1978, Circulation.
[16] J. Cohn,et al. Hemodynamic effect of dobutamine in patients with severe heart failure. , 1975, The American journal of cardiology.
[17] C. Dollery,et al. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine. , 1974, The Lancet.
[18] J. Cohn,et al. Comparative Hemodynamic Effects of Inotropic and Vasodilator Drugs in Severe Heart Failure , 1977, Circulation.
[19] H. Loeb,et al. Comparative Responses to Dobutamine and Nitroprusside in Patients with Chronic Low Output Cardiac Failure , 1977, Circulation.
[20] C. Raper,et al. Beta-adrenoceptor selectivity of dobutamine: in vivo and in vitro studies. , 1984, Journal of cardiovascular pharmacology.
[21] C. Liang,et al. Dobutamine infusion in conscious dogs with and without autonomic nervous system inhibition: effects on systemic hemodynamics, regional blood flows and cardiac metabolism. , 1979, The Journal of pharmacology and experimental therapeutics.
[22] R. Ruffolo,et al. Vascular effects of the stereoisomers of dobutamine. , 1983, The Journal of pharmacology and experimental therapeutics.
[23] L. Resnekov,et al. Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine. , 1977, Progress in cardiovascular diseases.
[24] P. Murphy,et al. Disposition of dobutamine in the dog. , 1976, The Journal of pharmacology and experimental therapeutics.